ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The com...
| Metric Name | Value | Trend | |
|---|---|---|---|
| Dividend Yield | 1.0% | ||
| P/E Ratio | 25.8x | ||
| Revenue | 4.927 B | ||
| Net Income to Company | 1.249 B |
| RMD | Peers | Sector | |
|---|---|---|---|
Market Cap | 32.206 B | 601.1 M | 64.23 M |
Price % of 52 Week High | 83.5% | 68.8% | 61.6% |
Dividend Yield | 1.0% | 0.0% | 0.0% |
Shareholder Yield | 3.2% | -4.3% | -0.6% |
1 Year Price Total Return | 15.6% | -3.1% | -11.6% |
Beta (5 Year) | 0.74 | 1.22 | 0.64 |
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Jun-23 | Jun-24 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 4,223 | 4,685 | 4,927 | 1,163 | 1,282 |
| Operating Income | 1,152 | 1,384 | 1,560 | 339 | 417 |
| Net Profit | 898 | 1,021 | 1,249 | 209 | 345 |
| Diluted EPS | 6.09 | 6.92 | 8.47 | 1.42 | 2.34 |
| EBITDA | 1,292 | 1,534 | 1,712 | 377 | 457 |
| Balance Sheet | |||||
| Cash & ST Invest. | 228 | 238 | 522 | 218 | 522 |
| Current Assets | 2,368 | 2,358 | 2,836 | 2,378 | 2,836 |
| Total Assets | 6,752 | 6,872 | 7,141 | 6,905 | 7,141 |
| Current Liabilities | 759 | 911 | 852 | 764 | 852 |
| Total Liabilities | 2,622 | 2,008 | 1,888 | 2,423 | 1,888 |
| Total Equity | 4,130 | 4,864 | 5,253 | 4,482 | 5,253 |
| Total Debt | 1,580 | 874 | 840 | 1,391 | 840 |
| Cash Flow Statement | |||||
| Cash Flow Operations | 693 | 1,401 | 1,476 | 273 | 309 |
| Cash From Investing | (1,160) | (270) | (114) | (41) | (37) |
| Cash From Financing | 423 | (1,119) | (1,027) | (239) | (148) |
| Free Cash Flow | 574 | 1,302 | 1,392 | 249 | 288 |